Benign prostate specific antigen distribution and associations with urological outcomes in community dwelling black and white men

Journal of Urology

Volumn 187, Issue 1, 2012, Pages 87-91

  Rhodes, Thomas ^a   Jacobson, Debra J ^b   McGree, Michaela E ^b   St Sauver, Jennifer L ^b   Sarma, Aruna V ^d   Girman, Cynthia J ^e   Lieber, Michael M ^b   Klee, George G ^c   Demissie, Kitaw ^a   Jacobsen, Steven J ^f  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b MAYO CLINIC   (United States)

^c Mayo Clinic   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

^f Kaiser Permanente Southern California ^*  (United States)

Author keywords

continental population groups; prostate; prostate specific antigen; prostatic hyperplasia; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RISK; CAUCASIAN; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ETHNICITY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGED; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RESIDENCE CHARACTERISTICS;

EID: 83555164654     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.09.061     Document Type: Article

References (26)

1. Prostate Cancer Screening: Prostate Specific Antigen (PSA) Test 2011 National Cancer Institute http://www.cancer.gov/cancertopics/factsheet/ Detection/PSA Accessed January 4, 2011
2. Clinical Guidelines: Prostate Specific Antigen 2011 American Urological Association http://www.auanet.org/content/media/psa09.pdf Accessed January 4, 2011
3. S.D. Mikolajczyk, L.S. Millar, and T.J. Wang "BPSA," a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia Urology 55 2000 41
4. S.D. Mikolajczyk, L.S. Marks, and A.W. Partin Free prostate-specific antigen in serum is becoming more complex Urology 59 2002 797
5. E.I. Canto, H. Singh, and S.F. Shariat Serum BPSA outperforms both total PSA and free PSA as a predictor of prostatic enlargement in men without prostate cancer Urology 63 2004 905
6. M.A. Khan, L.J. Sokoll, and D.W. Chan Clinical utility of proPSA and "benign" PSA when percent free PSA is less than 15% Urology 64 2004 1160
7. S.H. de Vries, R. Raaijmakers, and B.G. Blijenberg Additional use of [-2] precursor prostate-specific antigen and "benign" PSA at diagnosis in screen-detected prostate cancer Urology 65 2005 926
8. C.G. Chute, L.A. Panser, and C.J. Girman The prevalence of prostatism: a population-based survey of urinary symptoms J Urol 150 1993 85
9. J.T. Wei, D. Schottenfeld, and K. Cooper The natural history of lower urinary tract symptoms in black American men: relationships with aging, prostate size, flow rate and bothersomeness J Urol 165 2001 1521
10. M.J. Barry, F.J. Fowler Jr, and M.P. O'Leary The American Urological Association symptom index for benign prostatic hyperplasia The Measurement Committee of the American Urological Association J Urol 148 1992 1549
11. S.J. Jacobsen, H.A. Guess, and L. Panser A population-based study of health care-seeking behavior for treatment of urinary symptoms The Olmsted County Study of Urinary Symptoms and Health Status Among Men Arch Fam Med 2 1993 729
12. A.V. Sarma, J.T. Wei, and D.J. Jacobson Comparison of lower urinary tract symptom severity and associated bother between community-dwelling black and white men: the Olmsted County Study of Urinary Symptoms and Health Status and the Flint Men's Health Study Urology 61 2003 1086
13. L.A. Panser, C.G. Chute, and H.A. Guess The natural history of prostatism: the effects of non-response bias Int J Epidemiol 23 1994 1198
14. S.G. Heeringa, K.H. Alcser, and K. Doerr Potential selection bias in a community-based study of PSA levels in African-American men J Clin Epidemiol 54 2001 142
15. R.O. Roberts, S.J. Jacobsen, and D.J. Jacobson Longitudinal changes in peak urinary flow rates in a community based cohort J Urol 163 2000 107
16. T. Rhodes, C.J. Girman, and S.J. Jacobsen Longitudinal prostate growth rates during 5 years in randomly selected community men 40 to 79 years old J Urol 161 1999 1174
17. M.K. Terris, and T.A. Stamey Determination of prostate volume by transrectal ultrasound J Urol 145 1991 984
18. K.A. Cooney, M.S. Strawderman, and K.J. Wojno Age-specific distribution of serum prostate-specific antigen in a community-based study of African-American men Urology 57 2001 91
19. S.J. Jacobsen, G.G. Klee, and H. Lilja Stability of serum prostate-specific antigen determination across laboratory, assay, and storage time Urology 45 1995 447
20. J.E. Oesterling, M.A. Moyad, and G.L. Wright Jr An analytical comparison of the three most commonly used prostate-specific antigen assays: Tandem-R, Tandem-E, and IMx Urology 46 1995 524
21. S.J. Jacobsen, D.J. Jacobson, and C.J. Girman Natural history of prostatism: risk factors for acute urinary retention J Urol 158 1997 481
22. H.J. Linton, L.S. Marks, and L.S. Millar Benign prostate-specific antigen (BPSA) in serum is increased in benign prostate disease Clin Chem 49 2003 253
23. C. Mullins, M.S. Lucia, and S.W. Hayward A comprehensive approach toward novel serum biomarkers for benign prostatic hyperplasia: the MPSA Consortium J Urol 179 2008 1243
24. C. Stephan, H. Cammann, and S. Deger Benign prostatic hyperplasia-associated free prostate-specific antigen improves detection of prostate cancer in an artificial neural network Urology 74 2009 873
25. S.J. Jacobsen, E.J. Bergstralh, and H.A. Guess Predictive properties of serum-prostate-specific antigen testing in a community-based setting Arch Intern Med 156 1996 2462
26. D. Woodrum, and L. York Two-year stability of free and total PSA in frozen serum samples Urology 52 1998 247